Clinical Trial Update: Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia [Phase 1, Phase 2]

View source ↗

Summary

A Russian Phase 1/2 clinical trial is exploring mesenchymal cell therapy for septic shock and several forms of neutropenia, including drug-induced, chemotherapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Chemotherapy-induced Neutropenia in Oncology Hematology
• Drug-induced Neutropenia
• Septic Shock

Drugs mentioned

• Mesenchymal cells (mesenchymal stem cells)

Snippet

Sponsor: National Research Center for Hematology, Russia | Conditions: Septic Shock, Nonchemotherapy Drug-induced Neutropenia | Phase 1, Phase 2 | Status: UNKNOWN